Mobilization Test of BM Progenitor Cells With Plerixafor/AMD3100: Controlled Parallel Group Comparison Between Diabetic and Non Diabetic Subjects
Phase of Trial: Phase IV
Latest Information Update: 24 Mar 2015
Price : $35 *
At a glance
- Drugs Plerixafor (Primary)
- Indications Stem cell mobilisation
- Focus Pharmacodynamics; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 24 Mar 2015 Results of pooled analysis of this trial and two retrospective trials have been published in the Diabetes.
- 23 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.